Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What fueled the previous growth in the muscle spasticity market?

The market size for muscle spasticity has witnessed robust growth in recent times. It is predicted to increase from $4.19 billion in 2024 to $4.57 billion in 2025, with a compound annual growth rate (CAGR) of 9.1%. The substantial growth experienced in the past can be credited to amplified investments in research and development, enlargement of clinical indications, beneficial regulatory authorizations and repayment policies, a greater focus on the adoption of a varied approach, and a rise in cases of multiple sclerosis.

What will be the muscle spasticity market size in the future?

Anticipated to experience significant expansion in the approaching years, the muscle spasticity market is projected to reach the value of $6.41 billion by 2029, with an 8.8% compound annual growth rate (CAGR). This predicted growth within the estimated timeframe is largely accredited to the increasing emphasis on the creation and development of patient-focused care, broadening of distribution networks, commitment to enhancing life quality, development of specialized drug delivery systems, and the discovery of biomarkers. Notable trends projected to surface during the forecast period incorporate the adoption of reimbursement models based on value, the implementation of artificial intelligence and machine learning technologies, the usage of telehealth and remote patient monitoring technologies, neurostimulation techniques, and approaches to regenerative medicine.

Get your muscle spasticity market report here!

https://www.thebusinessresearchcompany.com/report/muscle-spasticity-global-market-report

What main drivers are fueling expansion in the muscle spasticity market?

The muscle spasticity market is anticipated to be propelled by the growing incidence of musculoskeletal disorders. Such disorders encompass conditions that affect the body’s muscles, bones, and joints, often leading to pain, stiffness, and hindered movement. The escalation in cases of musculoskeletal disorders can be credited to elements like aging populations, inactive lifestyles, and the rising occurrence of chronic conditions. Through alleviation of pain, mobility enhancement, complication prevention, and improvement of overall life quality and functional ability, muscle spasticity strives to mitigate the symptoms of these disorders. For instance, The Lancet, a UK medical journal, reported in November 2023 that about 494 million people worldwide suffered from various musculoskeletal disorders in 2020, with predictions suggesting a probable increase of up to 115% by 2050. Furthermore, in May 2022, Amgen, a US biopharmaceutical firm, projected an increase of 68% in the yearly occurrences of fractures caused by osteoporosis from 1.9 million in 2018 to 3.2 million by 2040. Hence, the growing incidence of musculoskeletal disorders is propelling the muscle spasticity market.

What key areas define the segmentation of the global muscle spasticity market?

The muscle spasticity market covered in this report is segmented –

1) By Drug Type: Baclofen, Botulinum Toxin, Diazepam, Dantrolene Sodium, Other Drugs

2) By Route Of Administration: Oral, Intramuscular, Other Routes

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Baclofen: Oral Baclofen, Intrathecal Baclofen (Pump)

2) By Botulinum Toxin: Botox (Botulinum Toxin Type A), Dysport (Botulinum Toxin Type A), Xeomin (Botulinum Toxin Type A), Myobloc (Botulinum Toxin Type B)

3) By Diazepam: Oral Diazepam, Injectable Diazepam

4) By Dantrolene Sodium: Oral Dantrolene, Injectable Dantrolene

5) By Other Drugs: Tizanidine, Clonidine, Gabapentin, Other Muscle Relaxants, Selective Serotonin Reuptake Inhibitors (SSRIs)

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18411&type=smp

Who are the dominant players expanding their reach in the muscle spasticity market?

Major companies operating in the muscle spasticity market are F. Hoffmann-La Roche AG, AbbVie Inc., Abbott Laboratories, Novartis AG, Medtronic plc, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Sun Pharmaceutical Industries Ltd., Ipsen Pharma, Hikma Pharmaceuticals plc, Endo Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals, Neurocrine Biosciences Inc., Merz Pharmaceuticals GmbH, Beximco Pharmaceuticals Ltd., ANI Pharmaceuticals Inc., Taj Pharmaceuticals Limited, Revance Therapeutics Inc., Acorda Therapeutics Inc., Mylan N.V., Camber Pharmaceuticals Inc., Saol Therapeutics Inc., Zydus Cadila

What are the key trends shaping the future of the muscle spasticity market?

Primary players in the muscle spasticity market are now directing their efforts towards the creation of oral suspensions for managing muscle spasms resulting from ailments like multiple sclerosis and spinal cord injuries. Oral suspensions are essentially liquid drugs that have scattered active constituents and are consumed orally. As a case in point, in April 2024, ANI Pharmaceuticals, an American pharmaceutical production firm, introduced its version of baclofen oral suspension. A generic counterpart of fleqsuvy, this oral suspension aims to ease muscle spasms by promoting muscle relaxation in patients affected by conditions like multiple sclerosis and spinal cord injuries.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18411

Which regions are emerging as leaders in the muscle spasticity market?

North America was the largest region in the muscle spasticity market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the muscle spasticity market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Muscle Wasting Disorders Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/muscle-wasting-disorders-global-market-report

Earth and Space Mining Sensors Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/earth-and-space-mining-sensors-global-market-report

Medical Spa Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/medical-spa-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: